Table 2 Distribution of genotypes in CF-patients and controls
From: The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis
Genotypes | CF patients | Controls | ||
|---|---|---|---|---|
n | % | n* | % | |
Promotor | ||||
CC | 20 | 35.7 | 26 | 44.1 |
CT | 31 | 55.4 | 28 | 47.5 |
TT | 5 | 8.9 | 5 | 8.5 |
Codon 10 | ||||
CC | 7 | 12.5 | 9 | 14.8 |
CT | 31 | 55.4 | 32 | 52.5 |
TT | 18 | 32.1 | 20 | 32.8 |
Codon 25 | ||||
GG | 50 | 89.3 | 55 | 88.7 |
GC | 6 | 10.7 | 6 | 9.7 |
CC | 0 | 0 | 1 | 1.6 |